Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA594518
Max Phase: Preclinical
Molecular Formula: C28H48N2O
Molecular Weight: 428.71
Molecule Type: Small molecule
Associated Items:
ID: ALA594518
Max Phase: Preclinical
Molecular Formula: C28H48N2O
Molecular Weight: 428.71
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](CNCCN1CCCC1)[C@H]1CC[C@H]2C3=CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Standard InChI: InChI=1S/C28H48N2O/c1-20(19-29-14-17-30-15-4-5-16-30)24-8-9-25-23-7-6-21-18-22(31)10-12-27(21,2)26(23)11-13-28(24,25)3/h7,20-22,24-26,29,31H,4-6,8-19H2,1-3H3/t20-,21+,22+,24-,25+,26+,27+,28-/m1/s1
Standard InChI Key: LWMASELEVXMBTL-JVAZTMFWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 428.71 | Molecular Weight (Monoisotopic): 428.3767 | AlogP: 5.25 | #Rotatable Bonds: 6 |
Polar Surface Area: 35.50 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.36 | CX LogP: 4.44 | CX LogD: 1.62 |
Aromatic Rings: 0 | Heavy Atoms: 31 | QED Weighted: 0.45 | Np Likeness Score: 1.58 |
1. Renard D, Perruchon J, Giera M, Müller J, Bracher F.. (2009) Side chain azasteroids and thiasteroids as sterol methyltransferase inhibitors in ergosterol biosynthesis., 17 (23): [PMID:19833521] [10.1016/j.bmc.2009.09.037] |
Source(1):